REG - Agronomics Limited - Agronomics leads US$5m investment in SuperMeat

AgronomicsAnnouncement

12/05/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260512:nRSL8703Da&default-theme=true

RNS Number : 8703D  Agronomics Limited  12 May 2026

12 May 2026

Agronomics Limited (https://agronomics.im/)

("Agronomics" or the "Company")

 

Agronomics leads US$ 5 million investment in SuperMeat

as part of targeted US$ 10 million Series A-4 financing

Issue of Equity and TVR

 

Agronomics Limited (AIM: ANIC), the leading listed company focused on clean
food, is pleased to announce that its portfolio company SuperMeat The Essence
of Meat Ltd. ("SuperMeat") has completed an initial closing of its Series A-4
financing round, raising US$ 6 million from Agronomics and New Agrarian
Company Limited ("New Agrarian"), an affiliated company. Milk & Honey
Ventures and other existing investors have also subscribed as part of a
targeted US$ 10 million financing.

 

Agronomics is investing US$ 5 million in the round through the issue of new
ordinary shares in the Company to SuperMeat, with New Agrarian participating
with a US$ 1 million cash investment.

 

The US$ 5 million consideration due from Agronomics will be satisfied in full
by the issue of 26,805,903 new ordinary shares of the Company, each new share
issued at a price equal to 13.78 pence (being the net asset value per share as
at 31 December 2025 and a premium of approximately 109% to the closing
mid-market price of 6.60 pence on 8 May 2026). The new shares shall be subject
to agreed lock-in and orderly market arrangements for a year from Admission.
In particular, SuperMeat shall be restricted in relation to its shareholding
from a) releasing more than 1/12(th) of the Agronomics shares per calendar
month, b) trading more than 10% of the prior day's volume, c) trading below
95% opening price, and d) appointing a third-party broker without first giving
a right of first refusal to the Company's appointed broker(s) to sell their
shares. The lock-in restrictions will not apply in certain circumstances such
as an offer for the Company.

 

SuperMeat is focused on the production of cultivated meat. The funding is
expected to support SuperMeat's commercialisation strategy through a
licensing-led model, with Switzerland identified as the initial target launch
market. SuperMeat has entered into an R&D and technology development
framework agreement with Ajinomoto and has extended its collaboration
agreement with Micarna, a subsidiary of Migros Group. Near-term milestones
include joint product development with Ajinomoto, a consumer validation study
led by Migros in Switzerland, process verification at commercial scale and a
Swiss regulatory submission. SuperMeat is also progressing a reorganisation
under a UK holding company as it continues its international expansion.

 

This follows SuperMeat's November 2025 fundraise of US$ 3.5 million through
the issue of a Simple Agreement for Future Equity (a "SAFE"), in which
Agronomics invested US$ 2 million, comprising US$ 0.75 million in cash and US$
1.25 million in new Agronomics shares, with Milk & Honey Ventures also
participating.

 

SuperMeat has also reported a number of operational milestones in recent
periods. In March 2024, it published a life-cycle analysis conducted by CE
Delft which estimated that its cultivated chicken could generate approximately
50% lower carbon emissions than conventionally farmed chicken. In November
2024, SuperMeat announced a cost-efficiency milestone indicating the potential
to produce 100% cultivated chicken (85% muscle, 15% fat) at an estimated cost
of approximately US$ 11.79 per pound at scale, broadly in line with premium
pasture-raised chicken in the US.

 

Jim Mellon, Executive Chair of Agronomics, said: "SuperMeat's Series A-4
financing marks an important step in its development and reflects continued
progress towards commercial launch. Having supported the business since 2020,
we believe the company is well positioned to advance its licensing-led
strategy and we are pleased to continue backing the team through this next
phase of growth."

 

Agronomics first invested in SuperMeat in December 2020 and, following this
investment, will have invested a total of £15.2 million. As part of the
Series A-4 round, the November 2025 SAFE investment has converted into equity,
with the shares now forming part of Agronomics' holding in SuperMeat.
Following the completion of this round, Agronomics will hold approximately
27.8% of SuperMeat on a fully diluted basis. The Series A 4 fundraise is not
expected to have a material impact on the Company's carrying value of its
investment in SuperMeat.

 

TVR

Application has been made for the new shares to be admitted to trading on AIM,
with admission expected on 15 May 2026. Post-admission, the Company's issued
share capital will total 1,083,381,111 Ordinary Shares, all with voting
rights. The Company does not hold any Ordinary Shares in Treasury.
Shareholders should therefore use 1,083,381,111 as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the Financial
Conduct Authority's Disclosure and Transparency Rules.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET
ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT, VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

About SuperMeat

SuperMeat stands at the forefront of the cultivated meat sector, championing
the move towards sustainable, nutritious, and animal-friendly meat production.
The company has established a pivotal continuous process, setting a new
standard in the production of cultivated meat. SuperMeat has formed strategic
partnerships with leading food companies, underscoring its commitment to
working together to create a better food system.

About Agronomics

Agronomics is a leading London-listed company focused on investment
opportunities within the field of clean food. The Company has established a
portfolio of over 20 companies developing technologies that produce food and
materials historically derived from animals, offering solutions for improved
sustainability, human health, and food security.

A full list of Agronomics' portfolio companies is available at
www.agronomics.im (http://www.agronomics.im/) .

For further information, please contact:

 Agronomics Limited   Beaumont              Cavendish Capital     Canaccord Genuity     33Seconds

                      Cornish Limited       Markets               Limited               Limited

                                            Limited
 The Company          Nomad                 Joint Broker          Joint Broker          Public Relations
 Jim Mellon           Roland Cornish        Giles Balleny         Andrew Potts          Jack Ferris

 Denham Eke           James Biddle          Michael Johnson       Harry Pardoe          Joel Watson
 +44 (0) 1624 639396  +44 (0) 207 628 3396  +44 (0) 207 397 8900  +44 (0) 207 523 8000  agronomics@33seconds.co

 info@agronomics.im

 

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFSDEFILLIR



            Copyright 2019 Regulatory News Service, all rights reserved